Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
603 hedge funds and large institutions have $12.4B invested in Exact Sciences in 2024 Q3 according to their latest regulatory filings, with 120 funds opening new positions, 171 increasing their positions, 201 reducing their positions, and 56 closing their positions.
125% more funds holding in top 10
Funds holding in top 10: 4 → 9 (+5)
114% more first-time investments, than exits
New positions opened: 120 | Existing positions closed: 56
27% more capital inflows, than outflows
Capital inflows: $1.37B | Capital outflows: $1.07B
15% more call options, than puts
Call options by funds: $194M | Put options by funds: $169M
10% more funds holding
Funds holding: 546 → 603 (+57)
1.8% more ownership
Funds ownership: 97.05% → 98.85% (+1.8%)
15% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 201
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$453M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$130M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$119M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$78.7M |
| 5 |
JP Morgan Chase
New York
|
+$51.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$122M |
| 2 |
State Street
Boston,
Massachusetts
|
-$86.3M |
| 3 |
Armistice Capital
New York
|
-$59.2M |
| 4 |
Braidwell
Stamford,
Connecticut
|
-$48.3M |
| 5 |
BlackRock
New York
|
-$45M |
EXAS Hedge Fund Activity: Q3 2024 in Review
603 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2024, worth a combined $12.4B — up 64% from $7.57B a quarter earlier.
Buyers outnumbered sellers: 120 funds opened new EXAS positions and 56 closed out — a net gain of 64 holders — while 171 added to existing stakes and 201 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $453M. The largest seller was Holocene Advisors, cutting an estimated $122M.
- 603 institutional investors held Exact Sciences (EXAS) as of Q3 2024, up from 546 in Q2 2024.
- Funds reported $12.4B of Exact Sciences stock for Q3 2024, up 64% quarter-over-quarter.
- 120 funds opened new Exact Sciences positions in Q3 2024 and 56 closed out, a net change of +64 holders.
- The largest Exact Sciences buyer in Q3 2024 was Fidelity Investments, an estimated $453M added.
- The largest Exact Sciences seller in Q3 2024 was Holocene Advisors, an estimated $122M sold.
Based on aggregated 13F filings for Q3 2024.